Claire Alette Cox

Claire Alette Cox

Auto-generated profile, based on publicly available information

Claire Alette Cox

Department of Pulmonary Diseases, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Respiratory Medicine
Verified
Journal Article
Closed access
CCClaire A. Cox
Claire A. Cox
IBIlse M. Boudewijn
Ilse M. Boudewijn
SVSebastiaan J. Vroegop
Sebastiaan J. Vroegop
SSSiebrig Schokker
Siebrig Schokker
ALAnne J. Lexmond
Anne J. Lexmond
MBMaarten van Den Berge
Maarten van Den Berge

22 June 2019 in Allergy
Verified
Journal Article
Closed access
PDF file
IBIlse M. Boudewijn
Ilse M. Boudewijn
ALAndy Lan
Andy Lan
AFAlen Faiz
Alen Faiz
CCClaire A. Cox
Claire A. Cox
SBSharon Brouwer
Sharon Brouwer
VGVictor Guryev
Victor Guryev

28 January 2019 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
CCClaire A. Cox
Claire A. Cox
IBIlse M. Boudewijn
Ilse M. Boudewijn
SVSebastiaan J. Vroegop
Sebastiaan J. Vroegop
SSSiebrig Schokker
Siebrig Schokker
ALAnne J. Lexmond
Anne J. Lexmond
MBMaarten van Den Berge
Maarten van Den Berge
Bronchial provocation is often used to confirm asthma. Dyspnea sensation, however, associates poorly with the evoked drop in FEV1. Provocation tests only use the large airways parameter FEV1, although dyspnea is associated with both large- and small airways dysfunction. Aim of this study was to explore if adenosine 5′-monophosphate (AMP) and adenosine evoke an equal dyspnea sensation and if dyspnea associates better with large or small airways dysfunction. We targeted large airways with AMP and small airways with dry powder adenosine in 59 asthmatic (ex)-smokers with ≥5 packyears, 14 ± 7 days apart. All subjects performed spirometry, impulse oscillometry (IOS), and Borg dyspnea score. In 36 subjects multiple breath nitrogen washout (MBNW) was additionally performed. We analyzed the association of the change (Δ) in Borg score with the change in large and small airways parameters, using univariate and multivariate linear regression analyses. MBNW was analyzed separately. Provocation with AMP and adenosine evoked similar levels of dyspnea. ΔFEV1 was not significantly associated with ΔBorg after either AMP or adenosine provocation, in both univariate and multivariate analyses. In multivariate linear regression, a decrease in FEF25–75 during adenosine provocation was independently associated with an increase in Borg. In the multivariate analyses for AMP provocation, no significant associations were found between ΔBorg and any large or small airways parameters. AMP and adenosine induce equally severe dyspnea sensations. Our results suggest that dyspnea induced with dry powder adenosine is related to small airways involvement, while neither large nor small airways dysfunction was associated with AMP-induced dyspnea. NCT01741285 at www.clinicaltrials.gov , first registered Dec 4th, 2012.

1 October 2020 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
CCClaire A. Cox
Claire A. Cox
JVJudith Vonk
Judith Vonk
HKHuib Kerstjens
Huib Kerstjens
MBMaarten van Den Berge
Maarten van Den Berge
NHNick H.T. Ten Hacken
Nick H.T. Ten Hacken
Background: The forced expiratory flows (FEFs) towards the end of the expiration may be more sensitive in detecting peripheral airways obstruction compared to the forced expiratory volume in 1 s and forced vital capacity (FVC). However, they are highly variable. A partial solution is to adjust the FEFs for FVC (FEF/FVC). Here we provide reference equations for these adjusted FEFs at 25%, 50%, 75% and 25–75% of FVC, which are currently lacking.Methods: We included pulmonary healthy, never-smoker adults; 14 472 subjects from Lifelines, a biobank for health research, and 338 subjects from the department's control cohorts (NORM and Fiddle). Reference equations were obtained by linear regression on 80% of the Lifelines dataset and validated on the remaining data. The best model was defined as the one with the highest adjusted R2-value. The difference in variability between adjusted and unadjusted FEFs was evaluated using the coefficient of variation.Results: For all adjusted FEFs, the best model contained age, height and weight. The adjustment improved the coefficient of variation of the FEF75from 39% to 36% and from 43% to 40%, respectively, in males and females. The highest percentage of explained variance by the reference equation was obtained for FEF75/FVC, 32%–38% for males, and 41%–46% for females, depending on the validation set.Conclusion: We developed reference equations for FVC-adjusted FEF values. We demonstrated minimally yet significantly improved variability. Future studies in obstructive airway diseases should demonstrate whether it is worthwhile to use these (predicted) adjusted FEF values.

1 February 2018 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
ALAnne J. Lexmond
Anne J. Lexmond
IBIlse M. Boudewijn
Ilse M. Boudewijn
PHPaul Hagedoorn
Paul Hagedoorn
SSSiebrig Schokker
Siebrig Schokker
CCClaire A. Cox
Claire A. Cox
MBMaarten van Den Berge
Maarten van Den Berge

11 May 2019 in Allergy
Verified
Journal Article
Open access
PDF file
CCClaire Alette Cox
Claire Alette Cox
JVJudith M. Vonk
Judith M. Vonk
HKHuib Kerstjens
Huib Kerstjens
MBMaarten van Den Berge
Maarten van Den Berge